Suchergebnisse - "Shah, Rashmi R"

PubPharm (147)

101

If a drug deemed 'safe' in nonclinical tests subsequently prolongs QT in phase 1 studies, how can its sponsor convince regulators to allow development to proceed?

enthalten in: Pharmacology & therapeutics | 2008

von Shah, R.

102

If a drug deemed ‘safe’ in nonclinical tests subsequently prolongs QT in phase 1 studies, how can its sponsor convince regulators to allow development to proceed?

enthalten in: Pharmacology & therapeutics | 2008

von Shah, R.

103

Evaluating the QT-Liability of a Drug during its Development

enthalten in: Pharmaceutical medicine | 2008

von Shah, R. | Morganroth, J.

104

Evaluating the QT-Liability of a Drug during its Development

enthalten in: Pharmaceutical medicine | 2008

von Shah, R. | Morganroth, J.

105

Evaluating the QT-Liability of a Drug during its Development

enthalten in: Pharmaceutical medicine | 2008

von Shah, R. | Morganroth, J.

106

If a drug deemed ‘safe’ in nonclinical tests subsequently prolongs QT in phase 1 studies, how can its sponsor convince regulators to allow development to proceed?

enthalten in: Pharmacology & therapeutics | 2008

von Shah, R.

107

ABC of Bayesian Approaches to Drug Development

enthalten in: International journal of pharmaceutical medicine | 2008

von Shah, R. | Morganroth, J.

108

Cardiac Repolarisation and Drug Regulation

enthalten in: Medical toxicology | 2007

von Shah, R.

109

Cardiac Repolarisation and Drug Regulation

enthalten in: Drug safety | 2007

von Shah, R.

110

Cardiac repolarisation and drug regulation : assessing cardiac safety 10 years after the CPMP guidance

enthalten in: Drug safety | 2007

von Shah, R.